SEC Form 4 · accession 0001104659-18-012890
SUPERNUS PHARMACEUTICALS, INC. · SUPN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Georges Gemayel
Director
Period of report
Feb 23, 2018
Accepted (ET)
Feb 27, 2018 · 5:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356576
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Buy) | $39.40 | Feb 23, 2018 | A | 8,613 | A | Feb 23, 2019 | Feb 23, 2028 | Common Stock | 8,613 | 8,613 | D |